Trinity Biotech plc

NasdaqGS:TRIB 주식 보고서

시가총액: US$19.7m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Trinity Biotech 미래 성장

Future 기준 확인 1/6

Trinity Biotech은 연간 수입과 매출이 각각 66.1%와 12.9% 증가할 것으로 예상되고 EPS는 연간 72.2%만큼 증가할 것으로 예상됩니다.

주요 정보

66.1%

수익 성장률

72.2%

EPS 성장률

Medical Equipment 수익 성장16.6%
매출 성장률12.9%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트29 May 2024

최근 미래 성장 업데이트

Recent updates

The Market Lifts Trinity Biotech plc (NASDAQ:TRIB) Shares 34% But It Can Do More

Jun 11
The Market Lifts Trinity Biotech plc (NASDAQ:TRIB) Shares 34% But It Can Do More

Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%

Mar 02
Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%

Trinity Biotech plc's (NASDAQ:TRIB) Shares Bounce 31% But Its Business Still Trails The Industry

Dec 18
Trinity Biotech plc's (NASDAQ:TRIB) Shares Bounce 31% But Its Business Still Trails The Industry

A Look At The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB)

Sep 12
A Look At The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB)

Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

Aug 08
Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

Insufficient Growth At Trinity Biotech plc (NASDAQ:TRIB) Hampers Share Price

Jun 09
Insufficient Growth At Trinity Biotech plc (NASDAQ:TRIB) Hampers Share Price

Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

Apr 23
Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

This Broker Just Slashed Their Trinity Biotech plc (NASDAQ:TRIB) Earnings Forecasts

Apr 23
This Broker Just Slashed Their Trinity Biotech plc (NASDAQ:TRIB) Earnings Forecasts

Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Mar 01
Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Trinity Biotech appoints former GE executive Aris Kekedjian as CEO

Oct 03

At US$1.22, Is Trinity Biotech plc (NASDAQ:TRIB) Worth Looking At Closely?

Sep 01
At US$1.22, Is Trinity Biotech plc (NASDAQ:TRIB) Worth Looking At Closely?

Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M

Jun 30

Returns Are Gaining Momentum At Trinity Biotech (NASDAQ:TRIB)

Jun 14
Returns Are Gaining Momentum At Trinity Biotech (NASDAQ:TRIB)

Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Mar 23
Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Is Trinity Biotech plc (NASDAQ:TRIB) Popular Amongst Insiders?

Feb 25
Is Trinity Biotech plc (NASDAQ:TRIB) Popular Amongst Insiders?

Trinity Biotech plc (NASDAQ:TRIB) Could Be Less Than A Year Away From Profitability

Feb 02
Trinity Biotech plc (NASDAQ:TRIB) Could Be Less Than A Year Away From Profitability

A Treatise On Trinity Biotech

Jan 13

Did You Miss Trinity Biotech's (NASDAQ:TRIB) Impressive 241% Share Price Gain?

Jan 05
Did You Miss Trinity Biotech's (NASDAQ:TRIB) Impressive 241% Share Price Gain?

What Do The Returns At Trinity Biotech (NASDAQ:TRIB) Mean Going Forward?

Dec 10
What Do The Returns At Trinity Biotech (NASDAQ:TRIB) Mean Going Forward?

Trinity Biotech (NASDAQ:TRIB) Takes On Some Risk With Its Use Of Debt

Nov 19
Trinity Biotech (NASDAQ:TRIB) Takes On Some Risk With Its Use Of Debt

Trinity Biotech EPS beats by $0.22, beats on revenue

Nov 17

수익 및 매출 성장 예측

NasdaqGS:TRIB - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202571-9-5-11
12/31/202463-19-12-81
3/31/202457-34-15-12N/A
12/31/202357-37-14-12N/A
9/30/202371-39-13-10N/A
6/30/202372-42-8-5N/A
3/31/202374-34-7-2N/A
12/31/202263-44-7-1N/A
9/30/202276-32-62N/A
6/30/202279-22-53N/A
3/31/202286-13-26N/A
12/31/202181-2513N/A
9/30/2021106-81120N/A
6/30/2021116-21827N/A
3/31/2021106-21929N/A
12/31/2020102-61424N/A
9/30/202091-20-17N/A
6/30/202083-27-65N/A
3/31/202090-31-210N/A
12/31/201990-29-65N/A
9/30/201994-30-411N/A
6/30/201993-29-79N/A
3/31/201995-23-79N/A
12/31/201897-23-107N/A
9/30/201897-39-107N/A
6/30/201899-40-88N/A
3/31/201899-40-610N/A
12/31/201799-39N/A9N/A
9/30/201798-36N/A8N/A
6/30/201799-37N/A10N/A
3/31/2017100-36N/A8N/A
12/31/2016100-39N/A10N/A
9/30/20161013N/A17N/A
6/30/201610116N/A14N/A
3/31/20169816N/A13N/A
12/31/201510022N/A13N/A
9/30/201510123N/A15N/A
6/30/201510315N/A17N/A
3/31/201510517N/A16N/A
12/31/201410515N/A16N/A
9/30/201410318N/A8N/A
6/30/201410010N/A6N/A
3/31/20149510N/A8N/A
12/31/20139110N/A9N/A
9/30/2013869N/A15N/A
6/30/20138317N/A17N/A

애널리스트 미래 성장 예측

수입 대 저축률: TRIB 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: TRIB 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: TRIB 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: TRIB 의 수익(연간 12.9% ) US 시장( 8.7% 보다 빠르게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: TRIB 의 수익(연간 12.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: TRIB 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견